Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.
These include a project that will establish a patient dataset of inherited retinal diseases; a rapid multi-omic liquid biopsy blood test using whole genome sequencing; research using next-generation sequencing to develop new solutions to...
CHICAGO – Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient's response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference & Exhibition.
But there are challenges to putting together an effective genomics program, said Jackie Rice, vice president for information technology and chief...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
NuraLogix introduces health measurement app in Singapore
Canadian health AI company NuraLogix has introduced its mobile health measurement app in Singapore.
Anura uses proprietary transdermal optical imaging technology, which captures blood information from a person's face through a video camera. It can measure various vital parameters, including blood pressure, heart rate, stress level, cardiac...
Remote patient-monitoring company Athelas scored $132 million across two funding rounds, earning the startup unicorn status with a valuation of $1.5 billion.
General Catalyst and Tribe Capital each led one of the financing rounds. Other participants include Sequoia Capital, YCombinator, Greenoaks, Human Capital and Initialized Capital.
Athelas' flagship product, the Athelas One, uses a finger...
SeqOne Genomics, a French digital health startup focused on genomic analysis solutions for personalised medicine, has announced a €20 million Series A funding round.
The round was led by Omnes, Merieux Equity Partners and the Software Club.
The investments will go straight into the company’s venture to accelerate machine learning adoption and big data integration with the vision to better support...
Canadian startup Deep Genomics scored $180 million in Series C funding for its artificial intelligence technology designed to help program and prioritize transformational RNA therapeutics for genetic diseases.
The round was led by SoftBank Vision Fund 2* with participation from Canadian Pension Plan Investment Board (CPP Investments), Fidelity Management & Research Company LLC, Alexandria...
The Emirati Genome Program, an initiative focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates (UAE), has partnered with Abu Dhabi Health Services Company (SEHA) to increase individual participation.
The partnership was inaugurated last week with a three-day sample collection event for SEHA’s Emirati employees.
As part of the agreement, new sample...
A new “first of its kind” institution aimed at enhancing local genomic research – as well as diagnosing and treating patients with genetic disorders – has been unveiled in the United Arab Emirates (UAE).
The Center for Genomic Discovery is a joint venture between the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Al Jalila Genomics Center of the Al Jalila Children’s...
SNP chips, a type of DNA microarray frequently employed by consumer genomics companies, are "extremely unreliable" when identifying clinically-relevant variants that are rare among the general population, according to a retrospective study recently published in The BMJ.
The investigation, conducted by researchers from the University of Exeter, reviewed sequencing data from nearly 50,000...
_8_26.jpeg?itok=5qFMCFxo "A piggy bank next to a stethoscope and a pile of coins")
_21.jpg?itok=8NhLGhop)
.jpg?itok=cMozmt6F "The “first of its kind” institution aims at enhancing local genomic research, and diagnosing and treating patients with genetic disorders. Its launch coincides with the formation of the board of the Emirati Genome Program.")
